MENINGOCOCCAL VACCINES
- corynebacterium diphtheriae crm-197 protein + meningococcal group a oligosaccharide + meningococcal group c oligosaccharide + meningococcal group w-135 oligosaccharide + meningococcal group y oligosaccharide (MENVEO)
- corynebacterium diphtheriae crm-197 protein + meningococcal group c oligosaccharide (MENJUGATE LIQUID)
- meningococcal group a polysaccharide-tetanus toxoid conjugate + meningococcal group c polysaccharide-tetanus toxoid conjugate + meningococcal group w polysaccharide-tetanus toxoid conjugate + meningococcal group y polysaccharide-tetanus toxoid conjugate + tetanus toxoid (MENQUADFI)
- meningococcal polysaccharide antigen group a + meningococcal polysaccharide antigen group c + meningococcal polysaccharide antigen group w-135 + meningococcal polysaccharide antigen group y + tetanus toxoid (NIMENRIX)
- meningococcal polysaccharide vaccine grp c + tetanus toxoid (NEISVAC-C)
- meningococcal polysaccharide-diphtheria toxoid conjugate, group a + meningococcal polysaccharide-diphtheria toxoid conjugate, group c + meningococcal polysaccharide-diphtheria toxoid conjugate, group w 135 + meningococcal polysaccharide-diphtheria toxoid conjugate, group y (MENACTRA)
- neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a + neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b (TRUMENBA)
- outer membrane vesicles (neisseria meningitidis group b nz98/254 strain) + recombinant neisseria meningitidis group b fhbp fusion protein + recombinant neisseria meningitidis group b nada protein + recombinant neisseria meningitidis group b nhba fusion protein (BEXSERO)
Using Health Canada Drug Database
updated on 14Sep2025.